SEC Form 4 · accession 0001209191-18-011605
Adverum Biotechnologies, Inc. · ADVM
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Patrick Machado
Director
Period of report
Feb 15, 2018
Accepted (ET)
Feb 20, 2018 · 7:19 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001501756
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (Right to Buy)F1 | $6.40 | Feb 15, 2018 | A | 10,000 | A | — | Feb 14, 2028 | Common Stock | 10,000 | 10,000 | D |
Explanation of responses
- F1All of the shares subject to the option shall vest in one installment on August 15, 2018, subject to the Reporting Person's continued service with the Issuer on such vesting date.